Sera Prognostics (SERA) Common Equity (2020 - 2026)
Sera Prognostics (SERA) posted Common Equity of $67.6 million for Q1 2026, down 10.33% on a QoQ basis from $75.4 million in Q4 2025, and down 28.66% year-over-year from $94.8 million in Q1 2025.
Sera Prognostics (SERA) Common Equity (2020 - 2026) Analysis & Trends
Sera Prognostics' Common Equity history runs 7 years deep, the most recent figure standing at $67.6 million for Q1 2026.
- Quarterly Common Equity fell 28.66% year-over-year to $67.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $67.6 million (down 28.66% YoY) and the FY2025 annual result came in at $75.4 million, up 57.75% from the prior year.
- Common Equity was $67.6 million for Q1 2026 at Sera Prognostics, down from $75.4 million in the prior quarter.
- Across five years, Common Equity topped out at $127.2 million in Q1 2022 and bottomed at $47.8 million in Q4 2024.
- A 5-year average of $82.5 million and a median of $81.1 million in 2023 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2022 — Common Equity jumped 197.56% — and 2024, when it tumbled 31.86%.
- Sera Prognostics' Common Equity stood at $98.9 million in 2022, then retreated by 29.09% to $70.2 million in 2023, then tumbled by 31.86% to $47.8 million in 2024, then surged by 57.75% to $75.4 million in 2025, then decreased by 10.33% to $67.6 million in 2026.
- Business Quant data shows SERA's Common Equity at $67.6 million in Q1 2026, $75.4 million in Q4 2025, and $82.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.15 Bn | 176.85 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 128.85 Bn | 125.98 Bn | 3.81 Bn | 38.00 Mn |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 68.66 Bn | 67.21 Bn | 3.61 Bn | 25.86 Bn |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 2.96 Bn |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.03 Bn | 1.98 Bn | 10.67 Bn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | 5.29 Bn |
| 9 | Koninklijke Philips | 25.31 Bn | 22.18 Bn | 2.07 Bn | 13.34 Bn |
| 10 | Sera Prognostics | 107.05 Mn | 107.05 Mn | -28,000.00 | 67.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.62 Mn |
| Dec 31, 2025 | 75.41 Mn |
| Sep 30, 2025 | 82.18 Mn |
| Jun 30, 2025 | 88.23 Mn |
| Mar 31, 2025 | 94.78 Mn |
| Dec 31, 2024 | 47.80 Mn |
| Sep 30, 2024 | 54.65 Mn |
| Jun 30, 2024 | 59.75 Mn |
| Mar 31, 2024 | 64.75 Mn |
| Dec 31, 2023 | 70.16 Mn |
| Sep 30, 2023 | 75.41 Mn |
| Jun 30, 2023 | 81.14 Mn |
| Mar 31, 2023 | 90.21 Mn |
| Dec 31, 2022 | 98.94 Mn |
| Sep 30, 2022 | 107.16 Mn |
| Jun 30, 2022 | 116.91 Mn |
| Mar 31, 2022 | 127.20 Mn |
| Dec 31, 2021 | 138.56 Mn |
| Sep 30, 2021 | 150.04 Mn |
| Jun 30, 2021 | -135.80 Mn |